Edition:
India

Ocular Therapeutix Inc (OCUL.OQ)

OCUL.OQ on NASDAQ Stock Exchange Global Market

6.45USD
21 Sep 2018
Change (% chg)

$0.02 (+0.31%)
Prev Close
$6.43
Open
$6.45
Day's High
$6.47
Day's Low
$6.36
Volume
334,325
Avg. Vol
92,137
52-wk High
$8.26
52-wk Low
$3.30

Chart for

About

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Its lead product candidate, DEXTENZA (dexamethasone insert) for intracanalicular use, has completed Phase... (more)

Overall

Beta: --
Market Cap(Mil.): $181.90
Shares Outstanding(Mil.): 29.06
Dividend: --
Yield (%): --

Financials

BRIEF-Ocular Therapeutix Reports Q1 Loss Per Share $0.40

* OCULAR THERAPEUTIX™ REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND BUSINESS UPDATE

09 May 2018

Earnings vs. Estimates